An ERRα-ZEB1 transcriptional signature predicts survival in triple-negative breast cancers.
- DOI
- 10.1186/s10020-026-01487-4
- Published
- 2026 May 8
- Container
- Molecular medicine (Cambridge, Mass.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s10020-026-01487-4,
title = {An ERRα-ZEB1 transcriptional signature predicts survival in triple-negative breast cancers.},
author = {Shi JR and Poulard C and Cerutti C and Trédan O and Le Romancer M and Shi TL and Vanacker JM},
year = {2026},
journal = {Molecular medicine (Cambridge, Mass.)},
doi = {10.1186/s10020-026-01487-4},
url = {https://doi.org/10.1186/s10020-026-01487-4}
}RIS
TY - JOUR TI - An ERRα-ZEB1 transcriptional signature predicts survival in triple-negative breast cancers. AU - Shi JR AU - Poulard C AU - Cerutti C AU - Trédan O AU - Le Romancer M AU - Shi TL AU - Vanacker JM PY - 2026 JO - Molecular medicine (Cambridge, Mass.) DO - 10.1186/s10020-026-01487-4 UR - https://doi.org/10.1186/s10020-026-01487-4 ER -
APA
JR, S., C, P., C, C., O, T., M, L. R., TL, S., & JM, V. (2026). An ERRα-ZEB1 transcriptional signature predicts survival in triple-negative breast cancers.. Molecular medicine (Cambridge, Mass.). https://doi.org/10.1186/s10020-026-01487-4
Source records
- pubmed · retrieved 2026-09-27T15:09:07.146Z